Amphista Therapeutics
Bart Dzikowski - Director
Platform
Cambridge, UK
Amphista Therapeutics is developing medicines for hard-to-treat diseases using next-generation targeted protein degradation approaches.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.